Last Close
Mar 25  •  02:27PM ET
3.15
Dollar change
+0.02
Percentage change
0.64
%
IndexRUT P/E- EPS (ttm)-0.56 Insider Own34.43% Shs Outstand98.86M Perf Week-12.50%
Market Cap311.35M Forward P/E- EPS next Y-0.08 Insider Trans1.45% Shs Float64.81M Perf Month22.09%
Enterprise Value381.54M PEG- EPS next Q-0.08 Inst Own35.71% Short Float13.86% Perf Quarter-7.08%
Income-50.26M P/S0.62 EPS this Y57.87% Inst Trans6.99% Short Ratio4.34 Perf Half Y-9.48%
Sales502.73M P/B- EPS next Y64.84% ROA-28.37% Short Interest8.98M Perf YTD-11.52%
Book/sh-0.16 P/C9.28 EPS next 5Y- ROE-3407.86% 52W High4.88 -35.45% Perf Year150.00%
Cash/sh0.34 P/FCF- EPS past 3/5Y-37.23% -17.58% ROIC-62.18% 52W Low0.97 224.74% Perf 3Y337.50%
Dividend Est.- EV/EBITDA- Sales past 3/5Y25.81% 21.80% Gross Margin13.82% Volatility9.39% 9.94% Perf 5Y-68.50%
Dividend TTM- EV/Sales0.76 EPS Y/Y TTM20.34% Oper. Margin-7.18% ATR (14)0.31 Perf 10Y-
Dividend Ex-Date- Quick Ratio1.35 Sales Y/Y TTM27.79% Profit Margin-10.00% RSI (14)53.24 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio1.59 EPS Q/Q55.70% SMA204.12% Beta0.19 Target Price7.00
Payout- Debt/Eq- Sales Q/Q41.58% SMA507.16% Rel Volume0.62 Prev Close3.13
Employees641 LT Debt/Eq- EarningsMar 12 AMC SMA200-5.66% Avg Volume2.07M Price3.15
IPOJun 04, 2020 Option/ShortYes / Yes EPS/Sales Surpr.33.33% 1.55% Trades Volume988,244 Change0.64%
Date Action Analyst Rating Change Price Target Change
Nov-25-25Initiated Needham Buy $5
Jul-23-25Initiated Noble Capital Markets Outperform $8
Jul-16-25Initiated B. Riley Securities Buy $6
May-15-25Initiated BTIG Research Buy $7
Feb-26-24Resumed Jefferies Buy $2.50
Sep-14-22Initiated Guggenheim Buy $7
Aug-15-22Initiated Jefferies Buy $10
Mar-13-26 08:30AM
Mar-12-26 11:03PM
04:05PM
Mar-11-26 09:27AM
Feb-26-26 06:00PM
08:00AM Loading…
08:00AM
Feb-25-26 08:00AM
Feb-23-26 08:00AM
Jan-12-26 08:00AM
Jan-09-26 08:00AM
Jan-05-26 08:30AM
Dec-01-25 08:30AM
Nov-21-25 05:20AM
Nov-14-25 12:06AM
Nov-13-25 05:30PM
04:05PM Loading…
04:05PM
04:04PM
Nov-12-25 06:25PM
07:26AM
Nov-05-25 09:15AM
Nov-04-25 05:50PM
Oct-29-25 07:15AM
Oct-22-25 04:47PM
Oct-21-25 09:45AM
Oct-01-25 08:00AM
Sep-29-25 08:00AM
Sep-22-25 08:00AM
Sep-18-25 09:35AM
Sep-02-25 04:05PM
Aug-18-25 08:00AM
03:14AM Loading…
Aug-14-25 03:14AM
Aug-13-25 04:05PM
04:04PM
Jul-24-25 04:05PM
Jul-14-25 04:05PM
Jul-09-25 07:20AM
Jun-30-25 04:05PM
Jun-03-25 08:00AM
May-14-25 04:06PM
04:05PM
May-13-25 07:08PM
04:05PM
May-08-25 08:00AM
May-07-25 05:03PM
May-01-25 05:48PM
Apr-30-25 06:04AM
Apr-26-25 11:00AM
Apr-23-25 08:00AM
Apr-22-25 04:05PM
Apr-01-25 10:04AM
Mar-31-25 08:00AM
Mar-26-25 03:02AM
Mar-25-25 06:28PM
Mar-24-25 09:05AM
06:01AM
06:00AM
Mar-04-25 08:00AM
Feb-26-25 08:00AM
Dec-18-24 04:05PM
Nov-13-24 04:05PM
Nov-11-24 08:00AM
Nov-04-24 07:09PM
Oct-23-24 08:00AM
Oct-14-24 08:00AM
Sep-30-24 08:00AM
Sep-23-24 08:00AM
Aug-13-24 04:05PM
Jul-23-24 08:00AM
May-29-24 08:00AM
May-22-24 08:00AM
May-15-24 03:14AM
May-14-24 06:05PM
04:05PM
May-07-24 04:05PM
Apr-23-24 08:00AM
Apr-08-24 08:00AM
Apr-04-24 08:00AM
Apr-01-24 01:35PM
Mar-27-24 08:52PM
05:34PM
04:05PM
Mar-21-24 09:35AM
Mar-14-24 08:09AM
Mar-06-24 08:00AM
Feb-27-24 04:05PM
Feb-20-24 08:00AM
Jan-25-24 08:00AM
Dec-04-23 08:00AM
Nov-16-23 05:04AM
Nov-11-23 12:43PM
Nov-08-23 05:50PM
04:05PM
Oct-18-23 08:03AM
Oct-11-23 04:05PM
Sep-26-23 04:05PM
Sep-18-23 08:00AM
Aug-09-23 08:10AM
Aug-08-23 04:40PM
Aug-02-23 06:16AM
Jul-31-23 08:00AM
The Oncology Institute, Inc. provides cancer care treatment services. It operates through the following business segments: Dispensary, Patient Care, and Clinical Trials and Other. The company was founded in 2007 and is headquartered in Cerritos, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Chernett Jorey10% OwnerMar 24 '26Buy3.11125,000388,75010,401,929Mar 25 09:33 AM
Chernett Jorey10% OwnerMar 20 '26Buy3.3525,00083,75010,276,929Mar 23 09:33 AM
Chernett Jorey10% OwnerMar 13 '26Buy2.92263,000767,96010,115,944Mar 17 07:40 PM
Chernett Jorey10% OwnerMar 17 '26Buy3.4275,000256,50010,251,929Mar 17 07:40 PM
Chernett Jorey10% OwnerMar 16 '26Buy3.2960,985200,64110,176,929Mar 17 07:40 PM
Carter Robert RossChief Financial OfficerJan 02 '26Sale3.56247879235,122Jan 05 05:04 PM
Hively BradDirectorDec 15 '25Sale3.7713,33350,291683,721Dec 16 04:30 PM
BRADFORD DANIEL HIVELYDirectorDec 15 '25Proposed Sale3.7713,33350,291Dec 15 04:07 PM
Pacala Mark LDirectorNov 18 '25Sale4.0050,000200,000174,971Nov 20 04:55 PM
MARK PACALADirectorNov 18 '25Proposed Sale4.0050,000200,000Nov 18 04:05 PM
M33 Growth I L.P.DirectorSep 04 '25Sale3.096,018,16818,596,1397,932,389Sep 05 06:12 AM
M33 Growth I L.P.DirectorSep 04 '25Sale3.09681,8322,106,861590,892Sep 05 06:12 AM
Hively BradDirectorAug 19 '25Sale4.0620,22182,097622,980Aug 21 03:13 PM
M33 Growth I L.P.DirectorJun 05 '25Sale3.05673,6762,054,71213,950,557Jun 09 04:15 PM
M33 Growth I L.P.DirectorJun 05 '25Sale3.0576,324232,7881,272,724Jun 09 04:15 PM
Hively BradDirectorJun 03 '25Option Exercise0.901,867,6051,682,5242,579,638Jun 05 06:51 PM
Hively BradDirectorJun 03 '25Sale2.871,976,1375,672,106603,501Jun 05 06:51 PM
TOI M, LLC10% OwnerJun 05 '25Proposed Sale3.20127,207407,062Jun 05 06:17 PM
M33 Growth I L.P.10% OwnerJun 05 '25Proposed Sale3.201,122,7933,592,938Jun 05 06:13 PM
BRADFORD DANIEL HIVELYDirectorJun 03 '25Proposed Sale2.8739,600113,652Jun 03 05:08 PM
BRADFORD DANIEL HIVELYDirectorJun 03 '25Proposed Sale2.871,936,5375,557,861Jun 03 04:27 PM
M33 Growth I L.P.DirectorMay 20 '25Sale2.711,796,4684,873,63814,624,233May 22 07:38 PM
M33 Growth I L.P.DirectorMay 20 '25Sale2.71203,532552,1621,349,048May 22 07:38 PM
TOI M, LLC10% OwnerMay 20 '25Proposed Sale3.06203,532622,808May 20 06:25 PM
M33 Growth I L.P.10% OwnerMay 20 '25Proposed Sale3.061,796,4685,497,192May 20 06:19 PM
Virnich DanielChief Executive OfficerMar 26 '25Buy1.0422,64023,584724,363Mar 28 05:50 PM
Podnos YaleChief Medical OfficerMar 26 '25Buy1.049,0569,43479,049Mar 28 05:48 PM
Pacala Mark LDirectorMar 26 '25Buy1.0490,56294,338224,971Mar 28 05:41 PM
Johnson Karen MarieDirectorMar 26 '25Buy1.0436,22437,735203,409Mar 28 05:36 PM
Hively BradDirectorMar 26 '25Buy1.049,0569,434675,809Mar 28 05:34 PM
Castle JeremyChief Operating OfficerMar 26 '25Buy1.049,0569,43490,386Mar 28 05:33 PM
Carter Robert RossChief Financial OfficerMar 26 '25Buy1.049,0569,43439,407Mar 28 05:27 PM
BARASCH RICHARD ADirectorMar 26 '25Buy1.041,358,4481,415,0951,775,641Mar 28 05:25 PM
Last Close
Mar 25  •  02:27PM ET
1.40
Dollar change
-0.05
Percentage change
-3.44
%
STIM Neuronetics Inc daily Stock Chart
IndexRUT P/E- EPS (ttm)-0.60 Insider Own48.22% Shs Outstand68.99M Perf Week4.07%
Market Cap97.34M Forward P/E- EPS next Y-0.32 Insider Trans4.95% Shs Float35.87M Perf Month10.63%
Enterprise Value157.14M PEG- EPS next Q-0.17 Inst Own34.67% Short Float26.09% Perf Quarter-8.77%
Income-39.00M P/S0.65 EPS this Y19.41% Inst Trans6.11% Short Ratio4.59 Perf Half Y-48.91%
Sales149.16M P/B4.33 EPS next Y32.82% ROA-27.61% Short Interest9.36M Perf YTD1.81%
Book/sh0.32 P/C2.83 EPS next 5Y32.68% ROE-155.73% 52W High4.97 -71.72% Perf Year-67.85%
Cash/sh0.50 P/FCF- EPS past 3/5Y24.64% 16.51% ROIC-36.41% 52W Low0.80 75.62% Perf 3Y-50.00%
Dividend Est.- EV/EBITDA- Sales past 3/5Y31.76% 24.81% Gross Margin46.15% Volatility17.78% 13.41% Perf 5Y-89.44%
Dividend TTM- EV/Sales1.05 EPS Y/Y TTM56.27% Oper. Margin-21.08% ATR (14)0.18 Perf 10Y-
Dividend Ex-Date- Quick Ratio1.87 Sales Y/Y TTM99.17% Profit Margin-26.15% RSI (14)49.20 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio2.02 EPS Q/Q68.60% SMA203.33% Beta0.88 Target Price4.33
Payout- Debt/Eq4.03 Sales Q/Q85.73% SMA50-11.04% Rel Volume0.34 Prev Close1.46
Employees658 LT Debt/Eq3.79 EarningsMar 17 BMO SMA200-44.50% Avg Volume2.04M Price1.40
IPOJun 28, 2018 Option/ShortYes / Yes EPS/Sales Surpr.5.21% 2.72% Trades Volume534,033 Change-3.44%
Date Action Analyst Rating Change Price Target Change
Aug-13-24Downgrade William Blair Outperform → Mkt Perform
Oct-13-21Downgrade William Blair Outperform → Mkt Perform
Oct-13-21Downgrade BTIG Research Buy → Neutral
Jan-22-21Upgrade William Blair Mkt Perform → Outperform
Feb-06-20Initiated BTIG Research Buy $11
Jul-24-18Initiated Canaccord Genuity Buy
Mar-17-26 12:46PM
08:17AM
07:50AM
07:45AM
Mar-03-26 08:30AM
12:20AM Loading…
Feb-11-26 12:20AM
Feb-10-26 04:34PM
Nov-20-25 08:30AM
Nov-12-25 10:33AM
Nov-04-25 04:08PM
08:40AM
07:39AM
07:05AM
Nov-03-25 08:09AM
Oct-31-25 04:30PM
08:32AM Loading…
Oct-30-25 08:32AM
Oct-21-25 08:30AM
Sep-17-25 08:32AM
Sep-02-25 03:49AM
Aug-06-25 04:45PM
Aug-05-25 08:20AM
07:19AM
07:05AM
Aug-04-25 04:30PM
10:04AM
Jul-30-25 08:32AM
Jul-22-25 08:30AM
Jul-15-25 07:30AM
Jul-09-25 07:20AM
Jun-19-25 07:00PM
08:31AM Loading…
Jun-10-25 08:31AM
Jun-02-25 04:30PM
May-14-25 08:31AM
May-07-25 03:09AM
May-06-25 08:20AM
07:20AM
07:10AM
May-05-25 04:30PM
07:40AM
Apr-30-25 05:50AM
Apr-22-25 08:30AM
Apr-02-25 03:26PM
Mar-31-25 08:31AM
Mar-29-25 11:45PM
Mar-27-25 04:30PM
Mar-18-25 09:55AM
Mar-05-25 02:06AM
Mar-04-25 11:29PM
07:36AM
07:10AM
Mar-03-25 04:30PM
07:20AM
Feb-22-25 05:08PM
Feb-21-25 08:30AM
Feb-07-25 04:30PM
07:54AM
Feb-06-25 04:23PM
Feb-03-25 07:27PM
Jan-29-25 08:31AM
Jan-13-25 08:00AM
Dec-18-24 04:30PM
Dec-16-24 04:30PM
Dec-10-24 10:00AM
Nov-20-24 08:30AM
Nov-13-24 02:10AM
Nov-12-24 06:45PM
04:30PM
08:20AM
07:19AM
07:10AM
Nov-11-24 07:26AM
Oct-29-24 04:30PM
Oct-14-24 08:31AM
Oct-04-24 08:33AM
Sep-25-24 08:31AM
Sep-19-24 08:31AM
Sep-16-24 08:32AM
Sep-03-24 08:29AM
Aug-20-24 08:29AM
Aug-15-24 05:42AM
Aug-13-24 12:56PM
12:47PM
09:45AM
Aug-12-24 08:25AM
07:19AM
07:15AM
07:10AM
Aug-05-24 04:36PM
Aug-01-24 08:29AM
Jul-31-24 08:30AM
Jul-30-24 08:30AM
Jul-29-24 08:30AM
Jul-22-24 08:31AM
Jul-18-24 10:30AM
Jul-11-24 12:53PM
08:36AM
Jul-10-24 08:32AM
07:23AM
Jul-02-24 10:40AM
Jul-01-24 08:02AM
Neuronetics, Inc. is a commercial stage medical technology company, which focuses on designing, developing and marketing products that improve the quality of life for patients who suffer from neurohealth disorders. It operates through United States and International geographical segments. The company was founded by Steven B. Waite, Bruce J. Shook, Norman R. Weldon, and Thomas D. Weldon in 1998 and is headquartered in Malvern, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Pfanstiel StevenEVP, CFO and TreasurerMar 19 '26Sale1.3416,43122,018828,781Mar 24 05:52 PM
Sullivan Keith JFormer Officer & DirectorMar 19 '26Sale1.3446,28962,0271,590,924Mar 24 05:50 PM
MACAN WILLIAM ANDREWEVP, CLO and CSMar 19 '26Sale1.3416,00521,447897,270Mar 24 05:48 PM
Chernett Jorey10% OwnerMar 20 '26Buy1.41169,472238,9568,743,276Mar 23 09:34 AM
Chernett Jorey10% OwnerMar 18 '26Buy1.35607,400819,9908,123,804Mar 20 08:51 AM
Chernett Jorey10% OwnerMar 19 '26Buy1.33450,000598,5008,573,804Mar 20 08:51 AM
MACAN WILLIAM ANDREWOfficerMar 19 '26Proposed Sale1.3216,00521,123Mar 19 04:36 PM
Sullivan Keith JOfficerMar 19 '26Proposed Sale1.3246,28961,092Mar 19 04:25 PM
Chernett Jorey10% OwnerMar 17 '26Buy1.16531,000615,9607,516,404Mar 18 10:36 AM
MACAN WILLIAM ANDREWEVP, CLO and CSMar 04 '26Sale1.34609816879,525Mar 06 04:29 PM
MACAN WILLIAM ANDREWOfficerMar 04 '26Proposed Sale1.34609814Mar 04 03:09 PM
MACAN WILLIAM ANDREWEVP, CLO and CSFeb 26 '26Sale1.353,4274,626880,134Feb 27 04:34 PM
Sullivan Keith JPresident and CEOFeb 26 '26Sale1.358,45211,4101,524,713Feb 27 04:33 PM
Sullivan Keith JOfficerFeb 26 '26Proposed Sale1.348,45211,366Feb 26 03:33 PM
MACAN WILLIAM ANDREWOfficerFeb 26 '26Proposed Sale1.343,4274,609Feb 26 03:16 PM
Sullivan Keith JPresident and CEOFeb 12 '26Sale1.6533,84755,8481,533,165Feb 18 05:44 PM
MACAN WILLIAM ANDREWEVP, CLO and CSFeb 12 '26Sale1.6514,12023,298673,561Feb 18 05:42 PM
MACAN WILLIAM ANDREWEVP, CLO and CSFeb 10 '26Sale1.553,4855,402687,681Feb 12 04:32 PM
Sullivan Keith JPresident and CEOFeb 10 '26Sale1.5540,97663,5131,567,012Feb 12 04:31 PM
Sullivan Keith JOfficerFeb 12 '26Proposed Sale1.6533,84755,712Feb 12 03:19 PM
MACAN WILLIAM ANDREWOfficerFeb 12 '26Proposed Sale1.6514,12023,242Feb 12 03:12 PM
MACAN WILLIAM ANDREWOfficerFeb 10 '26Proposed Sale1.553,4855,392Feb 10 04:28 PM
Sullivan Keith JOfficerFeb 10 '26Proposed Sale1.5540,97663,398Feb 10 04:14 PM
Madryn Asset Management, LP10% OwnerAug 08 '25Sale3.723,500,00013,020,0001,142,351Aug 12 04:15 PM
MADRYN HEALTH PRTS II (CAY MAS10% OwnerAug 08 '25Proposed Sale3.722,925,55410,883,061Aug 08 04:55 PM
MADRYN HEALTH PARTNERS II, LP10% OwnerAug 08 '25Proposed Sale3.72192,806717,238Aug 08 04:54 PM
MADRYN SELECT OPPORTUNITIES, L10% OwnerAug 08 '25Proposed Sale3.72381,6401,419,701Aug 08 04:54 PM
Furlong StephenOfficerAug 07 '25Proposed Sale4.0998,635403,385Aug 07 04:52 PM
Furlong StephenEVP, CFO and TreasurerMay 12 '25Sale4.27193,460826,074416,593May 14 05:05 PM
Furlong StephenEVP, CFO and TreasurerMay 13 '25Sale4.166,54027,206410,053May 14 05:05 PM
Furlong StephenOfficerMay 13 '25Proposed Sale4.166,54027,190May 13 12:54 PM
Furlong StephenOfficerMay 12 '25Proposed Sale4.27193,460826,283May 12 04:40 PM
Last Close
Mar 25  •  02:27PM ET
3.02
Dollar change
+0.20
Percentage change
6.91
%
AIRS Airsculpt Technologies Inc daily Stock Chart
IndexRUT P/E- EPS (ttm)-0.30 Insider Own91.19% Shs Outstand62.44M Perf Week8.06%
Market Cap188.25M Forward P/E- EPS next Y-0.03 Insider Trans1.07% Shs Float5.50M Perf Month74.78%
Enterprise Value268.92M PEG- EPS next Q-0.03 Inst Own27.69% Short Float69.76% Perf Quarter40.23%
Income-17.98M P/S1.19 EPS this Y-846.00% Inst Trans-4.08% Short Ratio1.45 Perf Half Y-58.30%
Sales157.55M P/B2.29 EPS next Y78.42% ROA-9.13% Short Interest3.84M Perf YTD52.27%
Book/sh1.32 P/C34.80 EPS next 5Y- ROE-21.85% 52W High12.00 -74.87% Perf Year14.20%
Cash/sh0.09 P/FCF76.21 EPS past 3/5Y-172.08% -29.15% ROIC-11.59% 52W Low1.51 99.67% Perf 3Y-33.88%
Dividend Est.- EV/EBITDA31.16 Sales past 3/5Y10.60% 34.33% Gross Margin50.71% Volatility18.12% 16.36% Perf 5Y-
Dividend TTM- EV/Sales1.71 EPS Y/Y TTM-119.56% Oper. Margin-2.71% ATR (14)0.39 Perf 10Y-
Dividend Ex-DateAug 25, 2022 Quick Ratio0.51 Sales Y/Y TTM-16.54% Profit Margin-11.41% RSI (14)65.31 Recom2.33
Dividend Gr. 3/5Y- - Current Ratio0.51 EPS Q/Q-45.42% SMA2033.76% Beta2.29 Target Price6.00
Payout- Debt/Eq1.05 Sales Q/Q-17.76% SMA5030.89% Rel Volume0.91 Prev Close2.82
Employees389 LT Debt/Eq0.89 EarningsNov 07 BMO SMA200-39.04% Avg Volume2.65M Price3.02
IPOOct 29, 2021 Option/ShortYes / Yes EPS/Sales Surpr.-100.00% -12.07% Trades Volume1,875,344 Change6.91%
Date Action Analyst Rating Change Price Target Change
Oct-17-24Initiated BTIG Research Neutral
May-14-24Downgrade Leerink Partners Outperform → Market Perform $8.25 → $5
Nov-11-22Downgrade Piper Sandler Overweight → Neutral $4
Jun-16-22Downgrade Morgan Stanley Overweight → Equal-Weight $17 → $8.50
Nov-23-21Initiated SVB Leerink Outperform $26
Nov-23-21Initiated Raymond James Outperform $18
Nov-23-21Initiated Piper Sandler Overweight $22
Nov-23-21Initiated Morgan Stanley Overweight $17
Mar-16-26 06:45AM
Mar-06-26 01:00PM
Feb-24-26 10:45PM
Nov-17-25 05:32PM
Nov-07-25 07:15AM
06:00AM Loading…
06:00AM
Nov-06-25 07:24AM
Nov-05-25 06:25PM
Oct-31-25 06:45AM
Oct-23-25 11:10AM
Sep-26-25 09:40AM
Sep-19-25 12:00PM
Sep-03-25 12:00PM
Aug-19-25 08:00AM
Aug-13-25 06:00AM
09:40AM Loading…
Aug-08-25 09:40AM
Aug-02-25 03:07AM
Aug-01-25 07:10AM
06:00AM
Jul-31-25 09:30AM
Jul-25-25 06:45AM
Jul-02-25 02:39PM
Jun-16-25 06:45AM
Jun-11-25 04:05PM
Jun-10-25 06:55AM
Jun-09-25 04:25PM
May-27-25 12:00PM
May-03-25 03:02AM
May-02-25 11:02PM
01:12PM
07:10AM Loading…
07:10AM
06:00AM
May-01-25 09:32AM
Apr-25-25 06:45AM
Apr-17-25 05:27AM
Apr-14-25 07:18AM
Apr-02-25 06:07AM
Apr-01-25 12:16PM
Mar-26-25 05:33AM
Mar-24-25 05:29AM
Mar-15-25 03:02AM
12:48AM
Mar-14-25 07:10AM
06:00AM
Mar-11-25 09:15AM
Mar-06-25 06:45AM
Jan-13-25 06:45AM
Jan-07-25 06:45AM
Dec-17-24 06:45AM
Dec-10-24 10:42PM
Dec-02-24 01:22PM
Nov-09-24 02:04AM
01:34AM
Nov-08-24 09:30AM
07:10AM
06:00AM
Nov-07-24 07:09AM
Nov-05-24 11:17AM
Oct-24-24 06:30AM
Oct-15-24 08:05AM
Oct-01-24 12:48PM
Sep-24-24 01:30PM
Sep-19-24 08:32AM
Aug-23-24 08:30AM
Aug-19-24 12:00PM
Aug-10-24 08:18AM
Aug-09-24 10:52AM
09:30AM
07:25AM
06:33AM
06:10AM
06:00AM
Aug-07-24 09:15AM
Jul-25-24 06:45AM
Jul-15-24 11:57AM
Jun-17-24 06:00AM
May-31-24 09:36AM
May-24-24 09:55AM
09:35AM
May-13-24 03:06AM
May-11-24 10:19AM
May-10-24 03:32PM
01:48PM
10:53AM
09:30AM
07:15AM
06:00AM
May-08-24 09:15AM
Apr-30-24 07:00AM
Apr-29-24 08:30AM
Mar-19-24 08:30AM
Mar-18-24 07:00AM
Mar-12-24 03:59PM
Mar-10-24 10:18AM
Mar-07-24 07:00AM
Mar-04-24 08:30AM
Feb-29-24 09:00PM
Feb-28-24 08:52AM
Feb-27-24 09:53PM
09:30AM
AirSculpt Technologies, Inc. is a fat removal treatment under its brand, Elite Body Sculpture.. It provides custom body contouring using proprietary AirSculpt method that removes unwanted fat in a minimally invasive procedure, producing dramatic results. The company was founded by Aaron J. Rollins in 2012 and is headquartered in Miami Beach, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Chernett Jorey10% OwnerMar 23 '26Buy2.9150,000145,5006,843,761Mar 25 01:43 PM
Chernett Jorey10% OwnerMar 20 '26Buy2.7740,000110,8006,793,761Mar 23 09:33 AM
Chernett Jorey10% OwnerMar 19 '26Buy2.6477,702205,1336,753,761Mar 20 09:33 AM
Chernett Jorey10% OwnerMar 17 '26Buy2.5683,000212,4806,676,059Mar 18 10:36 AM
Chernett Jorey10% OwnerMar 16 '26Buy2.43105,848257,2116,592,059Mar 16 06:43 PM
Chernett Jorey10% OwnerMar 11 '26Buy2.1588,000189,2006,486,211Mar 11 05:30 PM
Chernett Jorey10% OwnerMar 06 '26Buy2.0045,60091,2006,398,211Mar 09 08:40 AM
Chernett Jorey10% OwnerMar 03 '26Buy1.7180,000136,8006,322,611Mar 04 06:58 PM
Chernett Jorey10% OwnerMar 04 '26Buy1.8730,00056,1006,352,611Mar 04 06:58 PM
Feinstein Adam TDirectorJun 09 '25Buy4.001,000,0004,000,00014,038,819Jun 11 05:06 PM
Rollins AaronExecutive ChairmanMay 19 '25Buy3.602,1187,62915,146,039May 20 04:11 PM
Jashnani YogeshChief Executive OfficerMay 07 '25Buy2.657,00018,532464,879May 07 05:56 PM